MPR

Evkeeza Approval Expanded to Include Younger HoFH Patients

The Food and Drug Administration (FDA) has expanded the approval of Evkeeza ® (evinacumab-dgnb) to include children aged 1 year and older with homozygous familial hypercholesterolemia (HoFH).
PharmiWeb

Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of investigational targeted oral peptide for treatment of plaque ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...

Guardrails, Not Roadblocks—How C-Suite Leaders Can Foster AI Innovation

Success in AI innovation and adoption is based on a new strategic blueprint, one where innovation is correlated with four key ...

Aima Technology Wins Multiple Cross-Industry Awards, Fully Demonstrating the Industry Development 'Upgrading' Concept

Aima ranked first in the 2025 China Customer Satisfaction Index C-CSI for its industry. Notably, only a few brands saw an ...
CNX Software

Linux 6.17 release – Main changes, Arm, RISC-V, and MIPS architectures

Here are some of the highlights of the Linux 6.17 release: Specific support for single-core processors has been removed, and ...

Rapid CNC Processing for Urgent Orders in Zhangzhou

This demand is commonly referred to as urgent order processing. In the Zhangzhou area, when enterprises face tight product ...

Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the EADV 2025 Congress

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...
National Law Review

DoD Finalizes Cybersecurity Maturity Model Certification Rule: What Defense Contractors Need to Know

On September 10, 2025, the U.S. Department of Defense (DoD) published a final rule that will shake up cybersecurity ...
The Manila Times

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine

Peer-reviewed results from Phase 1b/2a Trial of Anti-pTau Active Immunotherapy from AC Immune Published in eBioMedicine ...
eLife

Peer reviewers altered their recommendation based on whether they were cited or wanted to be cited. A matched study of open peer review at four journals

Peer reviewers judge the validity and quality of new research. These judgements would ideally be impartial, but some reviewers may give a more favourable review if they are cited in the article ...
Opinion
BusinessWorldOpinion

Digital transparency for a cleaner Philippine budget

Corruption in public spending isn’t an abstraction for Filipinos; we see it every time a “completed” project turns out to be a patch of mud or a slab that cracks after the first rain. This year’s ...